Pomalidomide is an aromatic amine that is thalidomide substituted at position 4 on the isoindole ring system by an amino group. Used for the treatment of multiple myeloma in patients who failed to respond to previous therapies. Among its listed roles, it functions as a antineoplastic agent, an immunomodulator and an angiogenesis inhibitor. It is grouped under the following drug class(es): Immunosuppressants. Its therapeutic use is listed as anti-cancer agents and antineoplastics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Actimid and Pomalyst. Its PubChem CID is 134780.
Pomalidomide
| CAS No | 19171-19-8 |
|---|---|
| Molecular Formula | C13H11N3O4 |
| Molecular Weight | 273.24 g/mol |
| Synonyms | 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pomalidomide is an aromatic amine that is thalidomide substituted at position 4 on the isoindole ring system by an amino group. Used for the treatment of multiple myeloma in patients who failed to respond to previous therapies.
The listed CAS number is 19171-19-8.
The listed molecular formula is C13H11N3O4.
The listed molecular weight is 273.24 g/mol.
4-amino-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione.
The source lists Actimid and Pomalyst.